Skip to content
Lower risk Medical device recall · FDA · Published May 16, 2024

BioFire GI Panel Recall: False Positive Vibrio Results with Cary Blair Transport Medium

BioFire Diagnostics recalls GI test kits that may give false positive Vibrio results when used with Remel Cary Blair transport medium. Affected kits include RFIT-ASY-0116 (30 tests) and RFIT-ASY-0104 (6 tests).

🇺🇸 FDA recall #Z-2514-2024Medical deviceBioFire ›
Take action

Contact the company

Recalling firmBioFire Diagnostics, LLC515 S Colorow Dr · Salt Lake City, UT 84108-1248
✎ GovInfoNow plain-language explainer

What happened, in plain English

BioFire Diagnostics is recalling two gastrointestinal test kits that may produce false positive results for Vibrio/Vibrio Cholerae when used with Remel Cary Blair transport medium. This could lead to incorrect diagnoses of serious infections if the test is used without proper handling. Read more at govinfonow.com/recall/55066-biofire-gi-panel-recall-false-positive-vibrio-results-with-cary.

Source Summary by GovInfoNow · govinfonow.com/recall/55066-biofire-gi-panel-recall-false-positive-vibrio-results-with-cary · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2514-2024

Cite this page

“BioFire GI Panel Recall: False Positive Vibrio Results with Cary Blair Transport Medium.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/55066-biofire-gi-panel-recall-false-positive-vibrio-results-with-cary. Based on FDA recall #Z-2514-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2514-2024%22&limit=1).

Why it’s dangerous

The test may show false positive results for Vibrio or Vibrio Cholerae when the Cary Blair transport medium is used. This could lead to unnecessary treatment or missed infections if the test is not properly handled.

Who’s affected

Individuals using the BioFire GI Panel test kits with Remel Cary Blair transport medium for stool samples. Those testing for gastrointestinal infections are most at risk of incorrect results.

How to tell if you have this one

Check for product part numbers RFIT-ASY-0116 (30 test kit) or RFIT-ASY-0104 (6 test kit). The kits are affected if used with Remel Cary Blair transport medium lot numbers 743930, 769240, 712258, 782425, 732357, or 742049.

  • Brand
    BioFire
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify if your BioFire GI Panel kit has part numbers RFIT-ASY-0116 (30 tests) or RFIT-ASY-0104 (6 tests).

  2. Verify Transport Medium

    Confirm if you used Remel Cary Blair transport medium with the kit, as this may cause false positive results.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 50 states.

Alaska: named in the noticeAKMaine: named in the noticeMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “U.S.: Nationwide - AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, Virgin Island, VT, WA,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 3 months after the firm started it.

1. Firm started the recall: May 16, 202412. FDA classified it Class II: Aug 6, 202423. Published in FDA’s Enforcement Report: Aug 14, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Do I need to stop using the test kit immediately?

No, the recall does not require stopping use. The kits may still be used with other transport media to avoid false positives.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2514-2024 (May 16, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2514-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA